Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth SelectMDx Liquid Biopsy Test

MDxHealth has launched its SelectMDx urine-based test for prostate cancer. SelectMDx for prostate cancer is a proprietary urine-based, molecular diagnostic test that offers a non-invasive method to identify patients at low risk for prostate cancer, the company said. The test will be commercially available in the US as a laboratory developed test.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.